We describe a strategy for molecular diagnosis in the autosomal recessive L
imb-girdle muscular dystrophies, a highly heterogeneous group of inherited
muscle-wasting diseases. Genetic mutation analysis is directed by immunoana
lysis of muscle biopsies using antibodies against a panel of muscular dystr
ophy-associated proteins. Performing the molecular analysis in this way gre
atly increases the chance that mutations will be found in the first gene ex
amined. The use of this strategy can significantly decrease the time involv
ed in determining the genetic fault in a patient with a clinical diagnosis
of recessive limb-girdle muscular dystrophy, as well as having a feedback e
ffect, which is useful in helping clinicians to identify subtle clinical di
fferences between the subtypes of the disease. The use of this approach has
so far helped us to identify mutations in ten sarcoglycanopathy (limb-gird
le muscular dystrophy 2C-2F) patients, and seven calpainopathy (Limb-girdle
muscular dystrophy 2A) patients. (C) 2000 Elsevier Science B.V. All rights
reserved.